Found: 8
Select item for more details and to access through your institution.
Phosphodiesterase type 5 inhibitor tadalafil reduces prostatic fibrosis via MiR-3126-3p/FGF9 axis in benign prostatic hyperplasia.
- Published in:
- Biology Direct, 2024, v. 19, n. 1, p. 1, doi. 10.1186/s13062-024-00504-y
- By:
- Publication type:
- Article
FADD as a key molecular player in cancer progression.
- Published in:
- Molecular Medicine, 2022, v. 28, n. 1, p. 1, doi. 10.1186/s10020-022-00560-y
- By:
- Publication type:
- Article
Copper Pyrithione (CuPT)-Catalyzed Oxidation of Secondary and Primary Benzyl Alcohols with Molecular oxygen or Air Under Mild Conditions.
- Published in:
- Catalysis Letters, 2023, v. 153, n. 9, p. 2665, doi. 10.1007/s10562-022-04172-3
- By:
- Publication type:
- Article
The regulation of PBXs and their emerging role in cancer.
- Published in:
- Journal of Cellular & Molecular Medicine, 2022, v. 26, n. 5, p. 1363, doi. 10.1111/jcmm.17196
- By:
- Publication type:
- Article
Non-coding RNAs regulating mitochondrial function in cardiovascular diseases.
- Published in:
- Journal of Molecular Medicine, 2023, v. 101, n. 5, p. 501, doi. 10.1007/s00109-023-02305-8
- By:
- Publication type:
- Article
Underlying mechanisms of epithelial splicing regulatory proteins in cancer progression.
- Published in:
- Journal of Molecular Medicine, 2022, v. 100, n. 11, p. 1539, doi. 10.1007/s00109-022-02257-5
- By:
- Publication type:
- Article
Non-coding RNA in cancer drug resistance: Underlying mechanisms and clinical applications.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.951864
- By:
- Publication type:
- Article
MOF-Derived Cu@N-C Catalyst for 1,3-Dipolar Cycloaddition Reaction.
- Published in:
- Nanomaterials (2079-4991), 2022, v. 12, n. 7, p. 1070, doi. 10.3390/nano12071070
- By:
- Publication type:
- Article